The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
Abstract Tuberculosis (TB) and atherosclerotic cardiovascular disease (ASCVD) have a close epidemiological and pathogenetic overlap. Thus, it becomes essential to understand the relationship between ASCVD and TB outcomes. From our retrospective cohort on drug-susceptible TB patients at the National...
Guardado en:
Autores principales: | Vignesh Chidambaram, Jennie Ruelas Castillo, Amudha Kumar, Justin Wei, Siqing Wang, Marie Gilbert Majella, Akshay Gupte, Jann-Yuan Wang, Petros C. Karakousis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d8f4950a93b4efbb6c8e077efd9ebd3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Yu-Cheng Kao, et al.
Publicado: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021) -
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Yi-Heng Li, et al.
Publicado: (2020) -
Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
por: David C Boettiger, et al.
Publicado: (2021) -
The gut microbiome in atherosclerotic cardiovascular disease
por: Zhuye Jie, et al.
Publicado: (2017)